David Snead
About David Snead
David Snead is the Associate Director of Chemical Development at Mirati Therapeutics, where he has worked since 2021. He has extensive experience in the field, having held positions at various organizations including the Medicines for All Institute, MIT, Merck, and Georgia-Pacific LLC.
Current Role at Mirati Therapeutics
David Snead serves as the Associate Director of Chemical Development at Mirati Therapeutics. He has held this position since 2021, contributing to the company's efforts in developing innovative therapies. His role involves overseeing chemical development processes and ensuring the successful progression of projects within the organization. Mirati Therapeutics is known for its focus on precision medicine, particularly in the field of oncology.
Previous Experience at Medicines for All Institute
Before joining Mirati Therapeutics, David Snead worked at the Medicines for All Institute as the Director of Research from 2018 to 2021. In this role, he was responsible for leading research initiatives aimed at improving access to essential medicines. His tenure at the institute was marked by efforts to enhance pharmaceutical development and manufacturing processes.
Academic Background in Chemistry
David Snead earned his Bachelor of Science (B.S.) in Chemistry from the University of North Carolina at Chapel Hill, where he studied from 2001 to 2005. He furthered his education by obtaining a Doctor of Philosophy (PhD) in Organic Chemistry from the University of Florida, completing his studies from 2005 to 2010. This academic foundation has equipped him with the necessary skills for his career in chemical development.
Professional Experience in the Pharmaceutical Industry
David Snead has extensive experience in the pharmaceutical industry. He worked at Merck as an Associate Principal Scientist in Process Chemistry from 2017 to 2018. Prior to that, he held positions at Georgia-Pacific LLC, first as a Development Chemist from 2013 to 2015 and then as a Senior Development Chemist in Innovation from 2015 to 2017. His roles involved developing and optimizing chemical processes for various applications.
Post-Doctoral Research at MIT
David Snead completed a post-doctoral associate position at the Massachusetts Institute of Technology (MIT) from 2011 to 2013. During this time, he engaged in advanced research in chemistry, contributing to the academic community and gaining valuable insights that have informed his subsequent work in the industry.